Madhu Pudipeddi
Chief Tech/Sci/R&D Officer at PRELUDE THERAPEUTICS INCORPORATED
Network origin in Madhu Pudipeddi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Madhu Pudipeddi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Compliance Officer Director of Finance/CFO | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ZS PHARMA INC | Pharmaceuticals: Major | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Michigan State University | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pittsburgh | College/University | Undergraduate Degree | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| Drexel University | College/University | Masters Business Admin | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| McGill University | College/University | Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| University of Florida | College/University | Doctorate Degree | |
| Ursinus College | College/University | Undergraduate Degree | |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Consultant / Advisor | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERUS N.V. | Biotechnology | Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
| Washington University School of Medicine | College/University | Doctorate Degree | |
| IMAGO BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Human Resources Officer | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| OMEGA ALPHA SPAC | Financial Conglomerates | Director/Board Member | |
| Sardona Therapeutics, Inc. | Director/Board Member | ||
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Orsenix LLC | Chief Executive Officer | ||
| ACELYRIN, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Synthekine, Inc.
 Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Human Resources Officer |
Statistics
International
| United States | 46 |
| Canada | 2 |
| Netherlands | 2 |
| Switzerland | 2 |
| Ireland | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 69 |
| Independent Dir/Board Member | 44 |
| Corporate Officer/Principal | 30 |
| Undergraduate Degree | 13 |
| Chief Tech/Sci/R&D Officer | 10 |
Most connected contacts
| Insiders | |
|---|---|
| David Bonita | 27 |
| Paul Friedman | 21 |
| Julian Baker | 20 |
| Mardi Dier | 18 |
| Martin Babler | 13 |
| Victor Sandor | 9 |
| Bryant Lim | 9 |
| Jane Huang | 8 |
| Andrew Combs | 7 |
| Krishna Vaddi | 5 |
| Lindsey Trickett | 5 |
| Aimee Crombie | 5 |
| Michele Porreca | 5 |
| Wan-Jen Hong | 5 |
| Peggy Scherle | 4 |
- Stock Market
- Insiders
- Madhu Pudipeddi
- Company connections
